Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure | Zendy

Barry M. Massie | Zendy; Joseph F. Collins | Zendy; Susan E. Ammon | Zendy; Paul W. Armstrong | Zendy; John G.F. Cleland | Zendy; Michael D. Ezekowitz | Zendy; Syed M. Jafri | Zendy; W Król | Zendy; Christopher M. O’Connor | Zendy; Kevin A. Schulman | Zendy; Koon Teo | Zendy; Stuart Warren | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure

Author(s) -

Barry M. Massie,

Joseph F. Collins,

Susan E. Ammon,

Paul W. Armstrong,

John G.F. Cleland,

Michael D. Ezekowitz,

Syed M. Jafri,

W Król,

Christopher M. O’Connor,

Kevin A. Schulman,

Koon Teo,

Stuart Warren

Publication year - 2009

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.108.801753

Subject(s) - medicine , warfarin , clopidogrel , aspirin , heart failure , cardiology , myocardial infarction , hazard ratio , ejection fraction , sinus rhythm , antithrombotic , stroke (engine) , randomized controlled trial , clinical endpoint , atrial fibrillation , anesthesia , confidence interval , mechanical engineering , engineering

Chronic heart failure remains a major cause of mortality and morbidity. The role of antithrombotic therapy in patients with chronic heart failure has long been debated. The objective of this study was to determine the optimal antithrombotic agent for heart failure patients with reduced ejection fractions who are in sinus rhythm.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research